Regenxbio (RGNX) Reports Q3 Loss of $1.52/Share

Regenxbio (NASDAQ: RGNX) reported Q3 EPS of ($1.52), versus ($0.73) reported last year. Revenue for the quarter came in at $1.1 million, versus $500 thousand reported last year.

For earnings history and earnings-related data on Regenxbio (RGNX) click here.

You May Also Be Interested In

• L3Harris CEO steps down amid conduct review, shares drop
• BitFuFu Inc. (FUFU) Misses Q2 EPS by 13c
• Bimergen Energy Corporation (BESS) Reports Q2 EPS of $0.22